Concepedia

Murphy Hentemann

MH

3

Publications

202

Citations

3

H-Index

2019

Active since

Affiliations

Novartis (United States)(Current)

Murphy Hentemann is an author at Novartis (United States) specializing in drug discovery, medicinal chemistry, and medicine.

Top concepts

Publications per year

2019–2024

3

Publications

3

6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors

Patrick Sarver, Michael Acker, Jeffrey T. Bagdanoff et al. · Journal of Medicinal Chemistry · 2019 · 85 citations · Full text

, , +15

Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors

Jeffrey T. Bagdanoff, Zhouliang Chen, Michael Acker et al. · Journal of Medicinal Chemistry · 2019 · 79 citations · Full text

, , +16

BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor

Warren Fiskus, Jessica Piel, Murphy Hentemann et al. · Blood · 2024 · 38 citations · Full text

Rows per page

1–3 of 3